Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban

Aim. Thrombin not only plays a central role in thrombus formation and platelet activation, but also in induction of inflammatory processes. Activated factor X (FXa) is traditionally known as an important player in the coagulation cascade responsible for thrombin generation. We assessed the hypothesi...

Full description

Bibliographic Details
Published in:	Mediators of Inflammation
Main Authors:	Qianxing Zhou, Florian Bea, Michael Preusch, Hongjie Wang, Berend Isermann, Khurrum Shahzad, Hugo A. Katus, Erwin Blessing
Format:	Article
Language:	English
Published:	Wiley 2011-01-01
Online Access:	http://dx.doi.org/10.1155/2011/432080

Similar Items

Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis
by: Preusch MR, et al.
Published: (2016-08-01)

Rhizoma coptidis Inhibits LPS-Induced MCP-1/CCL2 Production in Murine Macrophages via an AP-1 and NF𝜅B-Dependent Pathway
by: Andrew Remppis, et al.
Published: (2010-01-01)

SPAG5 deficiency activates autophagy to reduce atherosclerotic plaque formation in ApoE−/− mice
by: Liangyun Guo, et al.
Published: (2024-05-01)

The role of exercise training and the endocannabinoid system in atherosclerotic plaque burden and composition in Apo-E-deficient mice
by: Michalis Katsimpoulas, et al.
Published: (2016-11-01)

Transient increase in atherosclerotic plaque macrophage content following Streptococcus pneumoniae pneumonia in ApoE-deficient mice
by: Rohit Bazaz, et al.
Published: (2023-03-01)

Modulating the Gut Microbiota Improves Glucose Tolerance, Lipoprotein Profile and Atherosclerotic Plaque Development in ApoE-Deficient Mice.
by: Ida Rune, et al.
Published: (2016-01-01)

Elucidating the mechanisms of formononetin in modulating atherosclerotic plaque formation in ApoE-/- mice
by: Ying He, et al.
Published: (2024-02-01)

Gasdermin D Deficiency Limits the Transition of Atherosclerotic Plaques to an Inflammatory Phenotype in <i>ApoE</i> Knock-Out Mice
by: Pauline Puylaert, et al.
Published: (2022-05-01)

Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques
by: Jeroen Baardman, et al.
Published: (2020-12-01)

Possible Factor Xa Resistance in a Patient Who Failed Apixaban and Rivaroxaban
by: Ola Ali, et al.
Published: (2024-12-01)

Up-regulated expression of NHE1 and Netrin-1 in atherosclerotic plaque of ApoE-/-mice
by: YANG Hui, MO Xian-gang, WANG Lan, ZHANG Shi-yue
Published: (2020-06-01)

Capsanthin Inhibits Atherosclerotic Plaque Formation and Vascular Inflammation in ApoE<sup>−/−</sup> Mice
by: Sungmin Kim, et al.
Published: (2022-07-01)

Autophagosome activity in macrophage for atherosclerotic plaques in ApoE−/− mice enhanced by Tiaozhi Tongmai Granules
by: Chenglong Zheng, et al.
Published: (2015-07-01)

Extracranial carotid artery atherosclerotic plaque and APOE polymorphisms: a systematic review and meta-analysis
by: Sinéad Culleton, et al.
Published: (2023-11-01)

PAC1 deficiency reduces chondrogenesis in atherosclerotic lesions of hypercholesterolemic ApoE-deficient mice
by: C. Blümm, et al.
Published: (2023-11-01)

GPX4 overexpression does not alter atherosclerotic plaque development in ApoE knock-out mice
by: Isabelle Coornaert, et al.
Published: (2024-06-01)

Plasma levels of direct Xa inhibitors apixaban and rivaroxaban in patients with venous thromboembolism in clinical practice
by: I. Paskaleva, et al.
Published: (2025-05-01)

Chromogenic anti-Xa test: the ratio between heparin activity units and concentration of apixaban and rivaroxaban
by: E. V. Titaeva, et al.
Published: (2020-12-01)

Anti-Xa Activity Monitoring for Optimizing Rivaroxaban Dosage in Chinese Patients with Cerebral Venous Thrombosis
by: Xiaoming Zhang MD, et al.
Published: (2024-09-01)

Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients
by: Kaitlin Blotske PharmD, et al.
Published: (2025-02-01)

Neonatal Subcutaneous BCG Vaccination Decreases Atherosclerotic Plaque Number and Plaque Macrophage Content in <i>ApoE</i><sup>−/−</sup> Mice
by: Siroon Bekkering, et al.
Published: (2022-10-01)

Imaging the carotid atherosclerotic plaque
by: Sandra Neumann, et al.
Published: (2019-07-01)

Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice.
by: Hanna E Auvinen, et al.
Published: (2013-01-01)

Rivaroxaban‐calibrated chromogenic anti‐Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation
by: Fabienne Lucas, et al.
Published: (2021-10-01)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
by: Michał Kosowski, et al.
Published: (2022-07-01)

SFRP4 Reduces Atherosclerosis Plaque Formation in ApoE Deficient Mice
by: Hua Guan, et al.
Published: (2023-01-01)

HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease.
by: Martin Andrassy, et al.
Published: (2012-01-01)

Magnetic force microscopy of atherosclerotic plaque.
by: T. A. Alexeeva, et al.
Published: (2014-03-01)

Mechanistic insights into the regression of atherosclerotic plaques
by: Jianshu Song, et al.
Published: (2024-11-01)

The effect of lypolitics on atherosclerotic plaques of the artery
by: Darmenov Oralbay, et al.
Published: (2024-01-01)

Magnetic force microscopy of atherosclerotic plaque
by: Alexeeva T.A., et al.
Published: (2014-03-01)

Clinical Molecular Imaging for Atherosclerotic Plaque
by: Anton Kondakov, et al.
Published: (2021-10-01)

The Elusive Origin of Atherosclerotic Plaque Calcification
by: Emmanuelle Canet-Soulas, et al.
Published: (2021-03-01)

Predictive thresholds of peak and trough anti-Xa levels for bleeding risk in rivaroxaban-treated nonvalvular atrial fibrillation
by: Mouhammad Rida Almouwannes, et al.
Published: (2025-08-01)

INHIBITION OF THE FACTOR XA (WITH RIVAROXABAN) SLOW DOWN PROGRESSION, PREVENTS COMPLICATION AND DECREASE MORTALITY IN CORONARY HEART DISEASE
by: V. N. Khirmanov
Published: (2018-04-01)

Xyloketal B Attenuates Atherosclerotic Plaque Formation and Endothelial Dysfunction in Apolipoprotein E Deficient Mice
by: Li-Yan Zhao, et al.
Published: (2015-04-01)

Correlation between carotid and/or subclavian atherosclerotic plaque and coronary atherosclerotic disease
by: Jing Li, et al.
Published: (2024-11-01)

Cardiovascular changes in atherosclerotic ApoE-deficient mice exposed to Co60 (γ) radiation.
by: Prem Kumarathasan, et al.
Published: (2013-01-01)

Contribution of multimodal ultrasound in evaluating the efficacy of lumbricus protein fast dissolving tablets against atherosclerotic plaques in ApoE(−/−) mice
by: Zhihao Lu, et al.
Published: (2025-05-01)

Error Propagation in the Simulation of Atherosclerotic Plaque Growth and the Prediction of Atherosclerotic Disease Progression
by: Antonis I. Sakellarios, et al.
Published: (2021-12-01)